國家衛生研究院 NHRI:Item 3990099045/16973
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12500/13673 (91%)
Visitors : 2477640      Online Users : 99
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
    •  Adv. Search
    Home ‧ Login ‧ Upload ‧ Help ‧ About ‧ Administer Goto mobile version


    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/16973


    Title: Exploring the causal relationship between metabolomics and thyroid cancer risk using genetic instrumental variables
    Authors: Chu, YY;Fan, HY;Lai, CJ;Tsai, MC
    Contributors: Center for Neuropsychiatric Research
    Abstract: Purpose: This study investigates potential causal links between circulating metabolites and thyroid cancer risk using genetic instrumental variables. Methods: Summary data from a genome-wide association study (GWAS) on circulating metabolites (N=7,824)and thyroid cancer GWAS summary data, including 1,054 cases and 490,920 controls, were analyzed. Using genetic variants and the inverse variance weighted method, the study assessed the causal impact of metabolites on thyroid cancer risk and identified affected metabolite levels. Results: Isovalerylcarnitine and but yrylcarnitine demonstrated significant positive associations with the risk of thyroid cancer, exhibiting odds ratios of 6.11 (95% CI: 1.26 to 29.71) and 1.77 (95% CI: 1.05 to 2.96), respectively. The research uncovered a nuanced relationship between thyroid cancer and seven metabolites: glutamine, citrulline, ornithine, 4-hydroxyhippurate, stearamide, N1-methyl-3-pyridone-4-carboxamide, and taurolithocholate 3-sulfate.Conclusion: Our research reveals potential links between various metabolites and thyroid cancer risk, enhancing our understanding of the role circulating metabolites play in the etiology of thyroid cancer.[Disclosure of COI by Responsible researcher] Lead presenter is not the Responsible researcher.[Lead presenter] We have no financial relationships to disclose.
    Date: 2025-01-03
    Relation: Cancer Science. 2025 Jan 03;116(S1):409.
    Link to: http://dx.doi.org/10.1111/cas.16413
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1347-9032&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:001401044101081
    Appears in Collections:[Others] Conference Papers/Meeting Abstract

    Files in This Item:

    File SizeFormat
    ISI001401044101081.pdf75KbAdobe PDF2View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback